Cerdulatinib
id:
cerdulatinib-320-11545303
title:
Cerdulatinib
text:
Cerdulatinib is a small molecule SYK/JAK kinase inhibitor in development for treatment of hematological malignancies. It has lowest nM IC50 values against TYK2, JAK1, JAK2, JAK3, FMS, and SYK. It is being developed by Portola Pharmaceuticals; in September 2018 the FDA granted orphan drug status to cerdulatinib for the treatment of peripheral T-cell lymphoma (PTCL).
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Cerdulatinib
date created:
date modified:
2024-04-24T21:08:52Z
main entity:
{"identifier":"Q27075860","url":"https://www.wikidata.org/entity/Q27075860"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/2/2e/Cerdulatinib.svg","width":943,"height":418}
fields total:
13
integrity:
15